To directly assess the clinical relevance of hnRNPA2B1 in CAD and atherosclerotic plaque, we further investigated hnRNPA2B1 protein expression in human coronary artery segments with different stages of atherosclerosis by immunohistochemical staining and measured the hnRNPA2B1 mRNA level in PBMCs of patients with CAD as well as controls. This evidence concerns the gene HNRNPA2B1 and coronary artery disorder.